C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/70 (2006.01) A61K 31/70 (2006.01) C07H 21/00 (2006.01) C07H 21/04 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2135591
The invention relates to novel stabilized oligonucleotides in which at least one non-terminal pyrimidine nucleoside is modified, and to their use as a diagnostic or pharmaceutical for the treatment of viral infections, cancer or diseases in which integrins or cell-cell adhesion receptors are active.
L'invention porte sur de nouveaux oligonucléotides stabilisés dans lesquels au moins un nucléoside pyrimidine non terminal est modifié, et sur leur utilisation comme agent diagnostique ou produit pharmaceutique pour traiter des infections virales, le cancer ou des maladies dans lesquelles les intégrines ou les récepteurs jouant un rôle dans l'adhésion intercellulaire sont actifs.
Helsberg Matthias
Kretzschmar Gerhard
Mag Matthias
Peyman Anuschirwan
Uhlmann Eugen
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hoechst Aktiengesellschaft
LandOfFree
Stabilized oligonucleotides and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized oligonucleotides and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized oligonucleotides and their use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2090272